A study on how UBT251 affects certain drugs in people with extra weight
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests if a new medicine called UBT251 changes how the body processes caffeine, midazolam (a sedative), and warfarin (a blood thinner). It is for generally healthy adults with a Body Mass Index (BMI) between 27 and 40.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 to 65 years old.
- Have a BMI between 27.0 and 39.9.
- Weigh at least 60 kilograms (about 132 pounds).
- Be generally healthy aside from having overweight or obesity.
- Not have taken any GLP-1, GIP, or glucagon receptor agonist medicines (like Ozempic or Wegovy) in the last 90 days.
- Not use certain prescription or over-the-counter drugs, herbs, or supplements that affect drug metabolism, except for routine vitamins, occasional acetaminophen, ibuprofen, or non-absorbed topical products.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests different doses of UBT251, a new medicine, to see how well it helps people lose weight. It may be an option if you have overweight or obesity and meet certain age and BMI requirements.
This study tests a new medicine, UBT251, to see if it affects how birth control pills work and how quickly food leaves the stomach. It is for women with overweight or obesity who cannot get pregnant.
This study tests a new drug called BI 3034701 to see how well people tolerate different doses. It may help with weight loss and related health issues.
This study tests a new medicine called PF-08653945 to see how it enters the blood in adults who are overweight or have obesity. The results will help doctors understand how the medicine works in the body.
This trial tests a new medicine called BGM0504 to help people with obesity lose weight. It may be an option if diet and exercise have not been enough and you qualify for a treatment study.
This study tests an experimental drug (NNC0487-0111) to see how it changes food intake, appetite, and the way your body processes food after meals. It is for adults with obesity who do not have diabetes.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.